Reaktionsgleichung
[CH2:1]=[C:2]([CH2:6][C:7]([N:9]1[CH2:14][CH2:13][O:12][CH2:11][CH2:10]1)=[O:8])[C:3]([OH:5])=[O:4].[F:15][C:16]([F:26])([F:25])[C:17]1[CH:24]=[CH:23][CH:22]=[CH:21][C:18]=1[CH2:19]S.CO.O[O:30][S:31]([O-:33])=O.[K+]>CN(C=O)C.CN(C1C=CN=CC=1)C>[N:9]1([C:7](=[O:8])[CH2:6][CH:2]([CH2:1][S:31]([CH2:19][C:18]2[CH:21]=[CH:22][CH:23]=[CH:24][C:17]=2[C:16]([F:15])([F:25])[F:26])(=[O:33])=[O:30])[C:3]([OH:5])=[O:4])[CH2:10][CH2:11][O:12][CH2:13][CH2:14]1Komponenten
7
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
A mixture of 2-methylene-4-morpholin-4-yl-4-oxo-butyric acid (2 g, 10.03 mmol), in DMF (5 mL), 2-trifluoromethylbenzyl mercaptan (1.93 g, 10.03 mmol) and DMAP (122 mg, 1.0 mmol) was stirred at ambient temperature for 16 hours. Methanol (200 mL) and a saturated aqueous solution of Oxone® (20 g, 32.5 mmol) were added with continued stirring for 2 hours. Methanol was removed under vacuum and the aqueous residue was diluted with 200 mL of water. The crystallized product was filtered, washed with water, and dried under vacuum to yield 4-morpholin-4-yl-4-oxo-2-(2-trifluoromethyl-benzylsulfonylmethyl)-butyric acid (0.95 g) as a white solid.
Aufarbeitung
- customMethanol was removed under vacuum
- additionthe aqueous residue was diluted with 200 mL of water
- filtrationThe crystallized product was filtered
- washwashed with water
- customdried under vacuum
Quellen und Nachweise
- ORD-Eintrag
- ord-d2b151c39d9a41da90bb419d88fb61a9
- Quelldatensatz
- uspto-grants-2006_06
- Patentnummer
- US07064123B1
Verknüpfte Notizen
Wird geladen…